Betaliq is a startup based in Germany, most recent round Series A.
Based in Germany, Betaliq is a startup. Its most recent tracked round is Series A.
Betaliq is a clinical-stage pharmaceutical company developing topical glaucoma treatments based on Novaliq’s proprietary water-free EyeSol® drug delivery technology to improve efficacy and patient tolerability.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.